The proteins encoded by the different alleles show different abilities to metabolize carcinogens and anticancer agents. It suggests an association between GST polymorphism and the risk for a variety of cancers as well as between said polymorphism and varying responses to cancer treatments. GSTs may also modify susceptibility in certain ethnic groups, showing ethnic dependent polymorphism.